* Exelixis Inc EXEL.OQ EXEL.O is expected to show a rise
in
quarterly revenue when it reports results on February 6 for the
period ending December 31 2023
* The Alameda California-based company is expected to
report a
13.3% increase in revenue to $480.175 million from $423.92
million a year ago, according to the mean estimate from 18
analysts, based on LSEG data. (Sales majority is on Total
revenue basis)
* LSEG's mean analyst estimate for Exelixis Inc is for
earnings
of 21 cents per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 16 "strong buy" or "buy," 3
"hold" and 1 "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Exelixis
Inc is
$27.00, above its last closing price of $21.75.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2023 0.10 0.10 0.00 Missed -100
Jun. 30 2023 0.16 0.16 0.25 Beat 56.3
Mar. 31 2023 0.15 0.15 0.12 Missed -19
Dec. 31 2022 -0.11 -0.12 -0.09 Beat 26.9
Sep. 0.18 0.19 0.23 Beat 22.2
30 2022
Jun. 30 2022 0.16 0.19 0.22 Beat 17.6
Mar. 31 2022 0.14 0.14 0.21 Beat 47.7
Dec. 31 2021 0.04 0.06 0.29 Beat 375.4
This summary was machine generated February 2 at 23:08 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)